Elective demand pushes Unilabs activity ahead of pre-pandemic levels

Strong demand from the return of elective surgery in the second-half boosted sales at pathology and cancer diagnostics specialist Unilabs in the year ended 31 December 2021.  The company, which trades as The Harley Street Breast Clinic and Unilabs, reported a 29% leap in revenue to £13.6m – ahead of pre-pandemic turnover of £12.8m in…

Membership Required

You must be a HM Subscriber to view this content.

Subscribe Now »

Already have an account?